It seems as if every orthopedic device company is getting involved in robot-assisted surgery — rolling out robots to assist surgeons operating on the knee, hip, shoulder or spine. Two events in recent years especially signaled that robots were coming into their own in the space: Stryker spent $1.7 billion for Mako Surgical in order […]
surgical robotics
Stryker acquires OrthoSensor and its knee surgery sensor tech
Stryker (NYSE:SYK) announced today that it has bought privately-held OrthoSensor and its Verasense intraoperative sensor tech that could further enhance the ortho giant’s Mako robots. The financial terms of the deal were not disclosed. Stryker officials in a news release noted that Verasense since 2011 has proved itself to be a unique knee balancing solution in […]
BREAKING: Johnson & Johnson finally unveils its new robot-assisted surgery system
Johnson & Johnson (NYSE:JNJ) today shared details on its surgical robotic platform that it says offers unrivaled flexibility and control compared to the rest of the market. The new system is designed with six arms to provide more control and flexibility in surgery, while its arms will be integrated into the operating table. Additionally, the platform […]
Intuitive Surgical up on mixed bag Q3
Intuitive Surgical (NSDQ:ISRG) shares ticked slightly up today on third-quarter results that were mixed compared to the consensus forecast. The Sunnyvale, Calif.-based company posted profits of $313.9 million, or $2.60 per share, on sales of $630.6 million for the three months ended Sept. 30, 2020, for a massive bottom-line gain from $68 million in profits this […]
Intuitive Surgical sales down more than a fifth in Q2
Intuitive Surgical (NSDQ:ISRG) posted second-quarter results today that beat Wall Street expectations — but the results still showed how much the COVID-19 pandemic has damaged sales for surgical robotics companies. The Sunnyvale, Calif.-based robot-assisted surgery company — the dominant player in the space — reported profits of $68 million, or $0.57 per diluted share, on sales […]
Johnson & Johnson to take its time on general surgery robot
Johnson & Johnson (NYSE:JNJ) has decided not to follow a 510(k) clearance pathway for its planned general surgery robot — with a goal to start first-in-human studies with the system by the second half of 2022. That was one of the major pieces of information to come out of the New Brunswick, N.J.–based company’s quarterly earnings […]
Smith+Nephew launches next-gen surgical robotics system
Competition continues to heat up in the robotic orthopedic surgery space, with Smith+Nephew (LON:SN) today announcing the launch of its next-gen Cori surgical system. Cleared by FDA and available for both total and unicompartmental knee arthroplasty, the handheld Cori robotics platform is meant to be faster than S+N’s previous Navio system. On top of Cori, […]
Origami Surgical raises $2.2m for robotic suturing tech
Origami Surgical last week filed an SEC Form D to confirm the sale of more than $2.2 million in an equity offering. The Madison, N.J.-based company, founded this year, filed a new notice for the sale of equity on March 23, 2020, with the intention of the offering lasting less than a year. According to […]
Procept Biorobotics taps industry veteran as new CEO
Procept BioRobotics recently announced that Reza Zadno, former CEO of ophthalmology tech company Avedro, has taken over the corner office at Procept. Zadno has more than three decades of leadership in the medical device industry, with a track record of successfully leading young companies to acquisitions. The latest was Avedro, which Glaukos (NYSE:GKOS) acquired for an […]
Avra Medical Robotics clears debt
Avra Medical Robotics (OTC:AVMR) announced yesterday that it paid off almost all its external corporate debt, including accrued interest. The Orlando, Fla.–based company said it cleared its debt with the exception of loans from its CEO and a loan note for $25,000, which is due on Dec. 31, 2020. One note of $25,000 is being converted […]
Titan Medical may put itself up for sale
Titan Medical (TSX:TMD) CEO David McNally told shareholders today that the company must raise $85 million to finish developing its Sport robot-assisted surgery device and file for FDA clearance. The Toronto-based medical device company is considering raising that money through equity or debt, licensing, merger or acquisition. Titan Medical lost nearly half its value in October […]
